Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Mayo Clinic
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
Thomas Jefferson University
Mayo Clinic
Mayo Clinic
City of Hope Medical Center
City of Hope Medical Center